ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
11.24
+0.36 (3.31%)
At close: Apr 24, 2026, 4:00 PM EDT
11.26
+0.02 (0.18%)
After-hours: Apr 24, 2026, 7:26 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $100.8 million as of April 24, 2026. Its market cap has increased by 444.50% in one year.
Market Cap
100.80M
Enterprise Value
94.65M
1-Year Change
444.50%
Ranking
Category
Stock Price
$11.24
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $100.80M, an increase of 361.91%. That is a compound annual growth rate of 11.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 100.80M | 586.14% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 106.99M |
| PepGen | 106.44M |
| Turn Therapeutics | 105.60M |
| Anixa Biosciences | 102.26M |
| Coeptis Therapeutics Holdings | 102.06M |
| Coya Therapeutics | 101.34M |
| Fractyl Health | 98.36M |
| NRx Pharmaceuticals | 97.12M |